<div id="readability-page-1"><p>Fulton Breakefield Broenniman LLC decreased its stake in  Marsh &amp; McLennan Companies, Inc. (NYSE:MMC - Free Report) by 86.6% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 8,832 shares of the financial services provider's stock after selling 56,878 shares during the period. Fulton Breakefield Broenniman LLC's holdings in Marsh &amp; McLennan Companies were worth $1,780,000 at the end of the most recent quarter.</p><ul><li>Big Banks Are Setting the Tone as Earnings Season Kicks Off</li></ul><p>Other institutional investors also recently modified their holdings of the company. Activest Wealth Management boosted its holdings in shares of  Marsh &amp; McLennan Companies by 2,775.0% during the 1st quarter. Activest Wealth Management now owns 115 shares of the financial services provider's stock valued at $28,000 after acquiring an additional 111 shares in the last quarter.  Headlands Technologies LLC acquired a new stake in shares of  Marsh &amp; McLennan Companies during the second quarter valued at about $29,000.  Westside Investment Management Inc. grew its holdings in shares of  Marsh &amp; McLennan Companies by 363.3% during the second quarter. Westside Investment Management Inc. now owns 139 shares of the financial services provider's stock worth $30,000 after purchasing an additional 109 shares during the last quarter.  Delos Wealth Advisors LLC bought a new position in  Marsh &amp; McLennan Companies in the 2nd quarter valued at approximately $32,000.  Finally, Access Investment Management LLC acquired a new stake in  Marsh &amp; McLennan Companies during the 2nd quarter worth approximately $39,000. 87.99% of the stock is currently owned by institutional investors and hedge funds. </p><h2>Insider Transactions at Marsh &amp; McLennan Companies</h2><p>In other Marsh &amp; McLennan Companies news, CEO John Q. Doyle sold 21,079 shares of the firm's stock in a transaction on Monday, December 1st. The shares were sold at an average price of $182.22, for a total value of $3,841,015.38. Following the completion of the sale, the chief executive officer directly owned 87,681 shares in the company, valued at approximately $15,977,231.82. This trade represents a 19.38% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 0.35% of the stock is currently owned by corporate insiders. </p><h2>Marsh &amp; McLennan Companies Stock Down 0.3%</h2><ul><li>Booz Allen Hamilton Earnings: 3 Bullish Signals for BAH Stock</li></ul><p>Shares of Marsh &amp; McLennan Companies stock opened at $187.10 on Friday. The stock's 50-day moving average is $183.04 and its 200 day moving average is $198.62. Marsh &amp; McLennan Companies, Inc. has a one year low of $174.18 and a one year high of $248.00. The firm has a market cap of $91.66 billion, a price-to-earnings ratio of 22.43, a PEG ratio of 3.22 and a beta of 0.75. The company has a debt-to-equity ratio of 1.19, a current ratio of 1.12 and a quick ratio of 1.12. </p><p>Marsh &amp; McLennan Companies (NYSE:MMC - Get Free Report) last issued its quarterly earnings results on Thursday, October 16th. The financial services provider reported $1.85 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.78 by $0.07. The firm had revenue of $6.35 billion for the quarter, compared to analyst estimates of $6.34 billion. Marsh &amp; McLennan Companies had a return on equity of 31.79% and a net margin of 15.60%.The company's revenue was up 11.5% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.63 earnings per share.  Equities research analysts anticipate that  Marsh &amp; McLennan Companies, Inc. will post 9.61 EPS for the current year. </p><h2>Analyst Ratings Changes</h2><p>Several equities analysts have issued reports on the stock. The Goldman Sachs Group upgraded shares of Marsh &amp; McLennan Companies from a &#34;sell&#34; rating to a &#34;neutral&#34; rating and decreased their price target for the company from $200.00 to $195.00 in a research report on Monday, October 20th. UBS Group lowered their target price on Marsh &amp; McLennan Companies from $258.00 to $257.00 and set a &#34;buy&#34; rating for the company in a research report on Wednesday, October 8th. Evercore ISI reduced their price target on Marsh &amp; McLennan Companies from $243.00 to $237.00 and set an &#34;outperform&#34; rating on the stock in a research report on Friday, October 17th. TD Cowen lowered their price objective on Marsh &amp; McLennan Companies from $213.00 to $200.00 and set a &#34;hold&#34; rating for the company in a research report on Monday, November 3rd. Finally, Barclays upgraded Marsh &amp; McLennan Companies from an &#34;equal weight&#34; rating to an &#34;overweight&#34; rating and reduced their target price for the company from $221.00 to $206.00 in a report on Thursday, November 20th. Eight research analysts have rated the stock with a Buy rating, ten have issued  a Hold rating and one  has issued  a Sell rating to the company's stock. According to MarketBeat.com, Marsh &amp; McLennan Companies  has a consensus rating of &#34;Hold&#34; and an average target price of $222.35.</p><p><b>View Our Latest Report on MMC</b></p><h2>About Marsh &amp; McLennan Companies</h2> (Free Report)<p>Marsh &amp; McLennan Companies <span>NYSE: MMC<span></span></span> is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.  </p><p>The firm operates through several well-known subsidiaries and business units that specialize in distinct services.</p><h2>Further Reading</h2><ul><li>Five stocks we like better than Marsh &amp; McLennan Companies</li><li>Do not delete, read immediately</li><li>INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off</li><li>Can Any Expenses Be Deducted From Capital Gains Tax?</li><li>Do you know what Amazon is planning for January 1?</li><li>Buffett, Gates and Bezos Quietly Dumping Stocks—Here's Why</li></ul><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1NQw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1NQw"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Marsh &amp; McLennan Companies Right Now?</h2><p>Before you consider Marsh &amp; McLennan Companies, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Marsh &amp; McLennan Companies wasn't on the list.</p><p>While Marsh &amp; McLennan Companies currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

<p>Fulton Breakefield Broenniman LLC reduced its stake in Marsh & McLennan Companies by 86.6% in Q3, selling 56,878 shares. The firm's holdings are now valued at $1.78 million. Other institutional investors also adjusted their positions in the company. Marsh & McLennan's stock opened at $187.10, with a market cap of $91.66 billion. The company reported Q3 earnings of $1.85 per share, surpassing estimates, with revenue up 11.5% year-over-year. Analysts have adjusted their ratings and price targets for the stock.</p>

Fulton Breakefield Broenniman LLC Sells 56,878 Shares of Marsh & McLennan Companies, Inc. $MMC